JPMorgan lowered the firm’s price target on Synopsys (SNPS) to $600 from $685 and keeps an Overweight rating on the shares. The company’s fiscal Q3 earnings were disappointing with weakness in the core chip design business due to intellectual property, the analyst tells investors in a research note. JPMorgan cut Synopsys’ earnings estimates to account for the near-term acquisition dilution and a slightly weaker core chip design franchise in fiscal 2026.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNPS:
- Synopsys price target lowered to $590 from $660 at KeyBanc
- Synopsys downgraded to Underperform from Buy at BofA
- Optimistic Long-Term Outlook for Synopsys Amid Short-Term Challenges and Strategic IP Transformation
- Synopsys downgraded to Neutral from Outperform at Baird
- Synopsys Faces Growth Challenges Amid Export Restrictions and Strategic Shifts